SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia

被引:98
作者
Zhang, L [1 ]
Li, XZ [1 ]
Poole, K [1 ]
机构
[1] Queens Univ, Dept Microbiol & Immunol, Kingston, ON K7L 3N6, Canada
关键词
D O I
10.1128/AAC.45.12.3497-3503.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Stenotrophomonas maltophilia is an emerging nosocomial pathogen that displays high-level intrinsic resistance to a variety of structurally unrelated antimicrobial agents. Efflux mechanisms are known to contribute to acquired multidrug resistance in this organism, and indeed, one such multidrug efflux system, SmeDEF, was recently identified. Still, the importance of SmeDEF to intrinsic antibiotic resistance in S. maltophilia had not yet been determined. Reverse transcription-PCR confirmed expression of the smeDEF genes in wild-type S. maltophilia, and deletion of smeE or smeF in wild-type strains rendered the mutants hypersusceptible to several antimicrobials, suggesting that SmeDEF contributes to intrinsic antimicrobial resistance in this organism. Expression of smeDEF was also enhanced in an in vitro-selected multidrug-resistant mutant, although deletion of smeF but not of smeE in these mutants compromised antimicrobial resistance. Apparently, hyperexpressed SmeF is capable of functioning with additional multidrug efflux components to promote multidrug resistance in S. maltophilia.
引用
收藏
页码:3497 / 3503
页数:7
相关论文
共 35 条
  • [1] Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides
    Aires, JR
    Köhler, T
    Nikaido, H
    Plésiat, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) : 2624 - 2628
  • [2] Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia
    Alonso, A
    Martínez, JL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) : 3079 - 3086
  • [3] Multiple antibiotic resistance in Stenotrophomonas maltophilia
    Alonso, A
    Martinez, JL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) : 1140 - 1142
  • [4] Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia
    Alonso, A
    Martinez, JL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) : 1879 - 1881
  • [5] Plasmid location and molecular heterogeneity of the L1 and L2 β-lactamase genes of Stenotrophomonas maltophilia
    Avison, MB
    Higgins, CS
    von Heldreich, CJ
    Bennett, PM
    Walsh, TR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) : 413 - 419
  • [6] STENOTROPHOMONAS MALTOPHILIA IN CYSTIC-FIBROSIS PATIENTS
    BALLESTERO, S
    VIRSEDA, I
    ESCOBAR, H
    SUAREZ, L
    BAQUERO, F
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (08) : 728 - 729
  • [7] BARCAK GJ, 1991, METHOD ENZYMOL, V204, P321
  • [8] Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia
    Denton, M
    Kerr, KG
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (01) : 57 - +
  • [9] Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples
    Denton, M
    Todd, NJ
    Kerr, KG
    Hawkey, PM
    Littlewood, JM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (07) : 1953 - 1958
  • [10] AN OVERVIEW OF THE KINETIC-PARAMETERS OF CLASS-B BETA-LACTAMASES
    FELICI, A
    AMICOSANTE, G
    ORATORE, A
    STROM, R
    LEDENT, P
    JORIS, B
    FANUEL, L
    FRERE, JM
    [J]. BIOCHEMICAL JOURNAL, 1993, 291 : 151 - 155